G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2538300
The correlation of clinical benefits and immune responses to peptides in cancer patients who were vaccinated with CTL-directed peptides is shown. The invention relates to a process for determining prognosis in a cancer patient vaccinated with a cancer antigen peptide-associated agent, which comprises measuring a level of an antibody specific to the cancer antigen peptide, and assessing whether the level is significantly increased as compared to the level at pre-vaccination.
La corrélation entre des bénéfices cliniques et des réponses immunitaires à des peptides chez des patients atteints d'un cancer, qui ont été vaccinés au moyen de peptides présentés aux lymphocytes T cytotoxiques, est montrée. Cette invention concerne un procédé pour établir un pronostic chez un patient atteint d'un cancer et vacciné au moyen d'un agent associé à un peptide antigénique tumoral, lequel procédé consiste à mesurer un niveau d'un anticorps spécifique au peptide antigénique tumoral et à évaluer si ce niveau s'est considérablement accru par rapport au niveau observé avant la vaccination.
Itoh Kyogo
Green Peptide Co. Ltd.
Kirby Eades Gale Baker
LandOfFree
Prognosis in cancer patients vaccinated with a cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prognosis in cancer patients vaccinated with a cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prognosis in cancer patients vaccinated with a cancer... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1861650